Literature DB >> 6808721

Analysis of antibody production induced by allogeneic tumor cells inoculated into the anterior chamber of the eye.

J Y Niederkorn, J W Streilein.   

Abstract

Humoral immune responses to alloantigens on P815 mastocytoma cells placed into the anterior chamber of murine eyes were studied. The results show that: (1) the amount of specific serum antibody produced by recipients of intracamerally injected P815 cells is directly proportional to the degree of immunogenetic disparity between the recipient and the injected cells; (2) destruction of allogeneic intraocular tumors is mediated, at least in part, by specific antibodies; and (3) retention of allogeneic tissue within the anterior chamber for 3 to 4 days after inoculation is essential to the elicitation of specific antibody formation. We conclude that alloantigens introduced into the anterior chamber are presented to the systemic immune apparatus in a very unique manner resulting in the preferential stimulation of specific antibody production without awakening specific cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6808721     DOI: 10.1097/00007890-198206000-00001

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

Review 1.  Experimental corneal allograft rejection.

Authors:  Bryan M Gebhardt; Weiyun Shi
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Corneal allograft rejection in bilateral penetrating keratoplasty: clinical and laboratory studies.

Authors:  R F Meyer
Journal:  Trans Am Ophthalmol Soc       Date:  1986

3.  Role of suppressor T cells in herpes simplex virus-induced immune deviation.

Authors:  J A Whittum; J Y Niederkorn; J P McCulley; J W Streilein
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

4.  Requirement for splenic CD4+ T cells in the immune privilege of the anterior chamber of the eye.

Authors:  M Takahashi; N Ishimaru; K Yanagi; K Saegusa; N Haneji; H Shiota; Y Hayashi
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

Review 5.  Influence of immune privilege on ocular tumor development.

Authors:  Kyle C McKenna; Peter W Chen
Journal:  Ocul Immunol Inflamm       Date:  2010-04       Impact factor: 3.070

6.  Evidence for multiple CD95-CD95 ligand interactions in anteriorchamber-associated immune deviation induced by soluble protein antigen.

Authors:  T Kezuka; J W Streilein
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

7.  Role of Th1 and Th2 cells in anterior chamber-associated immune deviation.

Authors:  X Y Li; L T D'Orazio; J Y Niederkorn
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

8.  A caveat for T cell transfer studies: generation of cytotoxic anti-Thy1.2 antibodies in Thy1.1 congenic mice given Thy1.2+ tumors or T cells.

Authors:  Kyle C McKenna; Rodolfo D Vicetti Miguel; Kelly M Beatty; Richard A Bilonick
Journal:  J Leukoc Biol       Date:  2010-10-19       Impact factor: 4.962

9.  In situ suppression of delayed-type hypersensitivity: another mechanism for sustaining the immune privilege of the anterior chamber.

Authors:  J L Benson; J Y Niederkorn
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

10.  Differential immune responses to fetal intracameral spinal cord and cortex cerebri grafts.

Authors:  M Shinoda; M Giacobini; R Schmidt-Kastner; K Trok; L Olson
Journal:  Exp Brain Res       Date:  1996-07       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.